<p>Immutep Limited（纳斯达克股票代码：IMMP - 获取免费报告）的股票在周四的交易中跌破了其 50 日移动平均线。该股票的 50 日移动平均线为 2.18 美元，最低交易价为 1.80 美元。Immutep 的股票最后交易价为 1.84 美元，成交量为 70,057 股。</p>
<h2>Immutep 股票上涨 0.5%</h2>
<ul>
<li>Immutep Ltd 股票为何近期飙升？</li>
</ul>
<p>该公司的 50 日移动平均价格为 2.18 美元，200 日移动平均价格为 2.35 美元。公司的流动比率为 18.25，速动比率为 18.25，债务股本比率为 0.01。</p>
<h2>机构投资者对 Immutep 的看法</h2>
<p>机构投资者和对冲基金最近增加或减少了对该公司的持股。XTX Topco Ltd 在第二季度购买了 Immutep 的新股份，价值约 26,000 美元。BNP Paribas Financial Markets 在第一季度将其在 Immutep 的持股增加了 15.4%。BNP Paribas Financial Markets 目前拥有 35,300 股该生物技术公司的股票，价值 82,000 美元，此前在该期间又购买了 4,700 股。XY Capital Ltd 在第二季度购买了 Immutep 的新股份，价值约 105,000 美元。Virtu Financial LLC 在第一季度将其在 Immutep 的持股增加了 269.4%。Virtu Financial LLC 目前拥有 45,062 股该生物技术公司的股票，价值 105,000 美元，此前在上个季度又购买了 32,864 股。最后，Oracle Investment Management Inc.在第一季度将其在 Immutep 的持股增加了 9.4%。Oracle Investment Management Inc.目前拥有 564,879 股该生物技术公司的股票，价值 1,316,000 美元，此前在该期间又购买了 48,449 股。2.32% 的股票由机构投资者持有。</p>
<h2>Immutep 公司简介</h2>
<p>(获取免费报告)</p>
<p>Immutep Limited 是一家临床阶段的生物技术公司，专注于开发用于癌症和自身免疫疾病的新型 LAG-3 免疫疗法。该公司致力于推进与淋巴细胞激活基因-3（LAG-3）相关的治疗，LAG-3 是一种在调节免疫系统中发挥重要作用的细胞表面分子。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票而非 Immutep</li>
<li>如何使用 MarketBeat Excel 股息计算器</li>
<li>吉利德股票飙升：是什么推动了这一势头？</li>
<li>万亿美元市值的意义超越数字</li>
<li>突破警报：高通刚刚按下了反弹按钮</li>
<li>如何投资保险公司：指南</li>
<li>Mercado Libre 股票降价：现在是购买的时机吗？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<p>→ 紧急：这次选举是操控的（来自 Porter &amp; Company）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDA1Nw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDA1Nw"/></p>
<h2>你现在应该投资 1,000 美元在 Immutep 吗？</h2>
<p>在考虑 Immutep 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Immutep 并不在名单上。</p>
<p>虽然 Immutep 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

IMMP

<p>Immutep（纳斯达克代码：IMMP）股价跌破其 50 日移动均线 0.18 美元，最低交易价为 0.80 美元，最终收于 0.84 美元，成交量为 70,057 股。该公司的流动比率为 18.25，债务股本比率为 0.01。机构投资者最近调整了他们的持股，像法国巴黎银行和 Virtu Financial 等公司显著增加了持股。Immutep 是一家临床阶段的生物技术公司，专注于开发用于癌症和自身免疫疾病的 LAG-3 免疫疗法</p>

<p>Shares of Immutep Limited (NASDAQ:IMMP - Get Free Report) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.18 and traded as low as $1.80. Immutep shares last traded at $1.84, with a volume of 70,057 shares traded.</p>
<div class="lb-trans"><p>Immutep Limited（纳斯达克股票代码：IMMP - 获取免费报告）的股票在周四的交易中跌破了其 50 日移动平均线。该股票的 50 日移动平均线为 2.18 美元，最低交易价为 1.80 美元。Immutep 的股票最后交易价为 1.84 美元，成交量为 70,057 股。</p>
</div><h2>Immutep Stock Up 0.5 %</h2>
<div class="lb-trans"><h2>Immutep 股票上涨 0.5%</h2>
</div><ul>
<li>Why Did Immutep Ltd Stock Soar Recently?</li>
</ul>
<div class="lb-trans"><ul>
<li>Immutep Ltd 股票为何近期飙升？</li>
</ul>
</div><p>The company's 50-day moving average price is $2.18 and its 200-day moving average price is $2.35. The company has a current ratio of 18.25, a quick ratio of 18.25 and a debt-to-equity ratio of 0.01.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 2.18 美元，200 日移动平均价格为 2.35 美元。公司的流动比率为 18.25，速动比率为 18.25，债务股本比率为 0.01。</p>
</div><h2>Institutional Investors Weigh In On Immutep</h2>
<div class="lb-trans"><h2>机构投资者对 Immutep 的看法</h2>
</div><p>Institutional investors and hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new position in shares of Immutep in the 2nd quarter valued at about $26,000. BNP Paribas Financial Markets grew its holdings in Immutep by 15.4% during the first quarter. BNP Paribas Financial Markets now owns 35,300 shares of the biotechnology company's stock worth $82,000 after purchasing an additional 4,700 shares during the period. XY Capital Ltd bought a new position in Immutep during the second quarter worth about $105,000. Virtu Financial LLC increased its position in Immutep by 269.4% during the first quarter. Virtu Financial LLC now owns 45,062 shares of the biotechnology company's stock worth $105,000 after buying an additional 32,864 shares during the last quarter. Finally, Oracle Investment Management Inc. raised its stake in Immutep by 9.4% in the first quarter. Oracle Investment Management Inc. now owns 564,879 shares of the biotechnology company's stock valued at $1,316,000 after buying an additional 48,449 shares during the period. 2.32% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近增加或减少了对该公司的持股。XTX Topco Ltd 在第二季度购买了 Immutep 的新股份，价值约 26,000 美元。BNP Paribas Financial Markets 在第一季度将其在 Immutep 的持股增加了 15.4%。BNP Paribas Financial Markets 目前拥有 35,300 股该生物技术公司的股票，价值 82,000 美元，此前在该期间又购买了 4,700 股。XY Capital Ltd 在第二季度购买了 Immutep 的新股份，价值约 105,000 美元。Virtu Financial LLC 在第一季度将其在 Immutep 的持股增加了 269.4%。Virtu Financial LLC 目前拥有 45,062 股该生物技术公司的股票，价值 105,000 美元，此前在上个季度又购买了 32,864 股。最后，Oracle Investment Management Inc.在第一季度将其在 Immutep 的持股增加了 9.4%。Oracle Investment Management Inc.目前拥有 564,879 股该生物技术公司的股票，价值 1,316,000 美元，此前在该期间又购买了 48,449 股。2.32% 的股票由机构投资者持有。</p>
</div><h2>Immutep Company Profile</h2>
<div class="lb-trans"><h2>Immutep 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.</p>
<div class="lb-trans"><p>Immutep Limited 是一家临床阶段的生物技术公司，专注于开发用于癌症和自身免疫疾病的新型 LAG-3 免疫疗法。该公司致力于推进与淋巴细胞激活基因-3（LAG-3）相关的治疗，LAG-3 是一种在调节免疫系统中发挥重要作用的细胞表面分子。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Immutep</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>Gilead’s Stock Surge: What’s Fueling the Momentum?</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>Breakout Alert: Qualcomm Just Hit The Rally Button</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>Mercado Libre Shares Go on Sale: Is Now the Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 Immutep</li>
<li>如何使用 MarketBeat Excel 股息计算器</li>
<li>吉利德股票飙升：是什么推动了这一势头？</li>
<li>万亿美元市值的意义超越数字</li>
<li>突破警报：高通刚刚按下了反弹按钮</li>
<li>如何投资保险公司：指南</li>
<li>Mercado Libre 股票降价：现在是购买的时机吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><p>→ Urgent: This election is rigged (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ 紧急：这次选举是操控的（来自 Porter &amp; Company）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDA1Nw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10057&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Immutep right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Immutep 吗？</h2>
</div><p>Before you consider Immutep, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Immutep 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Immutep wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Immutep 并不在名单上。</p>
</div><p>While Immutep currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Immutep 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Immutep（NASDAQ:IMMP）股价跌破五十日移动平均线 - 事情是这样的